James M. Sheil

452 total citations
13 papers, 396 citations indexed

About

James M. Sheil is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, James M. Sheil has authored 13 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in James M. Sheil's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). James M. Sheil is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). James M. Sheil collaborates with scholars based in United States and United Kingdom. James M. Sheil's co-authors include Michael J. Bevan, Mark W. Moore, Federico Carbone, Rui Sun, Leo Lefrançois, Cole T. Thomson, Rosana Schafer, Mohan L. Sopori, Yvonne Paterson and S G Zimmer and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and The Journal of Immunology.

In The Last Decade

James M. Sheil

13 papers receiving 386 citations

Peers

James M. Sheil
Maureen C. Gammon United States
B R Bloom United States
A K Berning United States
Lisa Flaherty United States
Jennifer J. Kuhns United States
H Spits Netherlands
Marina I. Lebedeva United States
Maureen C. Gammon United States
James M. Sheil
Citations per year, relative to James M. Sheil James M. Sheil (= 1×) peers Maureen C. Gammon

Countries citing papers authored by James M. Sheil

Since Specialization
Citations

This map shows the geographic impact of James M. Sheil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Sheil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Sheil more than expected).

Fields of papers citing papers by James M. Sheil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Sheil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Sheil. The network helps show where James M. Sheil may publish in the future.

Co-authorship network of co-authors of James M. Sheil

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Sheil. A scholar is included among the top collaborators of James M. Sheil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Sheil. James M. Sheil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sheil, James M., et al.. (2006). Propanil Exposure Induces Delayed but Sustained Abrogation of Cell-MediatedImmunity through Direct Interference with Cytotoxic T-LymphocyteEffectors. Environmental Health Perspectives. 114(7). 1059–1064. 9 indexed citations
2.
Schafer, Rosana & James M. Sheil. (1995). Superantigens and their role in infectious disease.. PubMed. 10. 369–90. 13 indexed citations
5.
6.
Sheil, James M., et al.. (1992). Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.. The Journal of Experimental Medicine. 175(2). 545–552. 19 indexed citations
7.
Nathenson, S.G., et al.. (1989). Use of Mutants to Analyze Regions on the H-2Kb Molecule for Interaction with Immune Receptors. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 521–528. 2 indexed citations
8.
Carbone, Federico, Mark W. Moore, James M. Sheil, & Michael J. Bevan. (1988). Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.. The Journal of Experimental Medicine. 167(6). 1767–1779. 171 indexed citations
9.
Sheil, James M., Michael J. Bevan, & Leo Lefrançois. (1987). Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.. The Journal of Immunology. 138(11). 3654–3660. 48 indexed citations
10.
Sheil, James M., Michael J. Bevan, & Linda A. Sherman. (1986). Immunoselection of structural H-2Kb variants: Use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant. Immunogenetics. 23(1). 52–59. 10 indexed citations
11.
Sheil, James M., P. H. Gallimore, S G Zimmer, & Mohan L. Sopori. (1984). Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.. The Journal of Immunology. 132(3). 1578–1582. 19 indexed citations
12.
Sim, Robert B., et al.. (1984). The Effect of Danazol on the Production of C1 Inhibitor in the Guinea Pig. PubMed. 1(1). 27–35. 6 indexed citations
13.
Sopori, Mohan L., James M. Sheil, Thomas L. Roszman, & William H. Brooks. (1981). T-lymphocyte heterogeneity in rat: Role of adherent T-cell subpopulation in the regulation of cytotoxic T-cell response to alloantigens. Cellular Immunology. 65(1). 103–114. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026